查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区单细胞多组体学市场：分析与预测（2023-2033）
市场调查报告书
商品编码
1430512

亚太地区单细胞多组体学市场：分析与预测（2023-2033）

Asia-Pacific Single-Cell Multi Omics Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 93 Pages | 商品交期: 1-5个工作天内

价格
主要市场统计数据
预测期 2023-2033
2023年评估 3亿美元
2033年预测 18.5亿美元
复合年增长率 20%

亚太地区单细胞多组体学市场规模预计将从 2023 年的 3 亿美元增至 2033 年的 18.5 亿美元，在 2023-2033 年预测期内复合年增长率为 20.00%。

该市场的推动因素包括：在大规模基因组研究中越来越多地使用单细胞 RNA定序(Sc-RNA)、向采用单细胞多组体学方法进行疾病筛检和诊断的个性化医疗的转变以及单细胞药物开发中的 RNA 定序：成长是由多种因素推动的，包括多组体学采用的增加。

由于几个关键因素，亚太地区 (APAC) 单细胞多组体学市场正在显着成长。这包括全部区域基因组学研究中越来越多地采用单细胞多组体学技术。随着个人化医疗受到关注，人们开始转向利用单细胞多组体学方法进行疾病筛检和诊断。此外，单细胞多组体学在药物开发过程中的应用在亚太地区呈现上升趋势。支持倡议研究和医疗基础设施进步的政府措施进一步促进了市场成长。由于人口众多且对精准医学的日益关注，亚太地区单细胞多体学市场为研究机构、製药公司和医疗保健提供者做好了准备，以更好地了解疾病并开发针对个别患者的标靶治疗。

本报告探讨了亚太地区单细胞多组体学市场，概述了市场、国家趋势以及参与该市场的公司概况。

目录

执行摘要

调查范围

第一章 市场

  • 市场展望
  • 市场概况
  • 产业展望
  • COVID-19 的影响
  • 业务动态

第二章 单细胞多组体学市场（按地区）

  • 亚太地区

第三章市场－竞争基准化分析与公司概况

  • 竞争基准化分析
    • 关键策略和发展
    • 市场占有率分析
    • 成长份额分析
    • 企业视觉图形
    • 活跃于多组体学生态系统的公司
  • 公司简介
    • BGI Group
    • Shilps Sciences
    • Takara Bio Inc.
Product Code: BHP1882SS

The Asia-Pacific Single-Cell Multi Omics Market Expected to Reach $1.85 Billion by 2033

Introduction to Asia-Pacific Single-Cell Multi-Omics Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$0.30 Billion
2033 Forecast$1.85 Billion
CAGR20%

The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033. The market is growing owing to various factors, such as the rising use of single-cell RNA sequencing (Sc-RNA) in large-scale genomics studies, a transition toward personalized medicine employing the single-cell multi-omics approach for disease screening and diagnostics, and increased uptake of single-cell multi-omics in drug development.

Market Introduction

The Asia-Pacific (APAC) single-cell multi-omics market is experiencing notable growth, driven by several key factors. This includes the increasing adoption of single-cell multi-omics technologies in genomics studies across the region. As personalized medicine gains prominence, there's a growing shift towards utilizing single-cell multi-omics approaches for disease screening and diagnostics. Moreover, the APAC region is witnessing a rising trend in the application of single-cell multi-omics in drug development processes. Government initiatives supporting genomic research and advancements in healthcare infrastructure further contribute to market growth. With a vast population and increasing focus on precision medicine, the APAC single-cell multi-omics market presents promising opportunities for research institutions, pharmaceutical companies, and healthcare providers to enhance understanding of diseases and develop targeted therapies tailored to individual patients.

Market Segmentation:

Segmentation 1: by Country

  • China
  • Japan
  • India
  • Australia
  • Singapore
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.

Competitive Strategy: The APAC single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in various applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • BGI Group
  • Shilps Sciences
  • Takara Bio Inc.

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion and Exclusion Criteria
  • 1.2 Market Overview
    • 1.2.1 Key Findings
    • 1.2.2 Current Market Scenario
      • 1.2.2.1 For Researchers
      • 1.2.2.2 For Diagnostics
  • 1.3 Industry Outlook
    • 1.3.1 Regulatory Framework
    • 1.3.2 Patent Analysis
      • 1.3.2.1 Awaited Technological Developments
      • 1.3.2.2 Patent Filing Trend (by Country)
      • 1.3.2.3 Patent Filing Trend (by Year)
    • 1.3.3 Key Trends
      • 1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
      • 1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
      • 1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
    • 1.3.4 Opportunity Assessment
    • 1.3.5 Product Benchmarking
    • 1.3.6 Clinical Trials
  • 1.4 COVID-19 Impact
    • 1.4.1 Pre-COVID-19
    • 1.4.2 During COVID-19
    • 1.4.3 Post COVID-19
  • 1.5 Business Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Business Drivers
      • 1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
      • 1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
      • 1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
      • 1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
    • 1.5.3 Business Restraints
      • 1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
      • 1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
    • 1.5.4 Business Opportunities
      • 1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
      • 1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations

2 Single-Cell Multi-Omics Market (by Region)

  • 2.1 Asia-Pacific
    • 2.1.1 Key Findings and Opportunity Assessment
    • 2.1.2 Market Dynamics
      • 2.1.2.1 Impact Analysis
    • 2.1.3 Sizing and Forecast Analysis
      • 2.1.3.1 Asia-Pacific Single-Cell Multi-Omics Market (by Country)
        • 2.1.3.1.1 China
        • 2.1.3.1.2 Japan
        • 2.1.3.1.3 India
        • 2.1.3.1.4 Singapore
        • 2.1.3.1.5 Australia
        • 2.1.3.1.6 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Benchmarking
    • 3.1.1 Key Strategies and Developments
      • 3.1.1.1 Funding Activities
      • 3.1.1.2 New Offerings
      • 3.1.1.3 Mergers and Acquisitions
      • 3.1.1.4 Partnership, Collaboration, and Business Expansion
    • 3.1.2 Market Share Analysis
    • 3.1.3 Growth Share Analysis
      • 3.1.3.1 By Application
      • 3.1.3.2 By Omics Type
      • 3.1.3.3 By Product Type
    • 3.1.4 Visual Graphics of the Companies
    • 3.1.5 Multi-Omics Ecosystem Active Players
  • 3.2 Company Profiles
    • 3.2.1 BGI Group
      • 3.2.1.1 Company Overview
      • 3.2.1.2 Role of BGI Group in the Single-Cell Multi-Omics Market
      • 3.2.1.3 Financials
      • 3.2.1.4 Analyst Perspective
    • 3.2.2 Shilps Sciences
      • 3.2.2.1 Company Overview
      • 3.2.2.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
      • 3.2.2.3 Analyst Perspective
    • 3.2.3 Takara Bio Inc.
      • 3.2.3.1 Company Overview
      • 3.2.3.2 Role of Takara Bio Inc. in the Single-Cell Multi-Omics Market
      • 3.2.3.3 Financials
      • 3.2.3.4 Analyst Perspective

List of Figures

  • Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
  • Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
  • Figure 3: Asia-Pacific Single-Cell Multi-Omics Market (by Application), % Share, 2022 and 2033
  • Figure 4: Single-Cell Multi-Omics Market: Research Methodology
  • Figure 5: Primary Research Methodology
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
  • Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
  • Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
  • Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
  • Figure 12: Data for Rare Diseases, 2020
  • Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
  • Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
  • Figure 15: Cost of Single Cell Sequencing (by Company)
  • Figure 16: Some of the Advancements in Single-Cell Metabolomics
  • Figure 17: Single-Cell Multi-Omics Market Share (by Region)
  • Figure 18: Asia-Pacific Single-Cell Multi-Omics Market Incremental Revenue Opportunity (by Country), $Million, 2023-2033
  • Figure 19: Asia-Pacific Single-Cell Multi-Omics Market, $Billion, 2022-2033
  • Figure 20: Asia-Pacific Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
  • Figure 21: China Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 22: Japan Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 23: India Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 24: Singapore Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 25: Australia Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 26: Rest-of-Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
  • Figure 28: Funding Activities, January 2018-March 2023
  • Figure 29: New Offerings, January 2018-March 2023
  • Figure 30: Mergers and Acquisitions, January 2018-March 2023
  • Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
  • Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
  • Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
  • Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
  • Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
  • Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
  • Figure 37: BGI Genomics.: Product Portfolio
  • Figure 38: BGI Genomics: Overall Financials, $Million, 2020-2022
  • Figure 39: Shilps Sciences: Product Portfolio
  • Figure 40: Takara Bio Inc.: Product Portfolio
  • Figure 41: Takara Bio Inc.: Overall Financials, $Million, 2020-2022
  • Figure 42: Takara Bio Inc.: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 43: Takara Bio Inc.: Net Revenue (by Region), $Million, 2020-2022
  • Figure 44: Takara Bio Inc.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
  • Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
  • Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
  • Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
  • Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
  • Table 8: Asia-Pacific Single-Cell Multi-Omics Market Dynamics, Impact Analysis
  • Table 9: Multi-Omics Ecosystem Active Players